NEW YORK, Aug. 10 (GenomeWeb News) - Shares in Stratagene were down 9.61, or $.98, at $9.22 in mid-afternoon trading today after the company revised its profit outlook for the remainder of the year
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.
The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.
Researchers find that people's genetics influence their success at university, but that it is not the only factor.
In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.